Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi-institutional retrospective analysis in 52 patients.

@article{Valle2009LaparoscopicHI,
  title={Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi-institutional retrospective analysis in 52 patients.},
  author={Mario Valle and Kurt van der Speeten and Alfredo Garofalo},
  journal={Journal of surgical oncology},
  year={2009},
  volume={100 4},
  pages={331-4}
}
Malignant ascites is a debilitating condition affecting cancer patients in their terminal stage of disease. Recently, laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) was introduced as a new approach. From September 2001 to August 2008, 52 patients were treated with this new modality. No treatment-related mortality was observed. Median survival was 98 days. One patient developed a clinical recurrence. Laparoscopic HIPEC is a safe and effective method for palliating… CONTINUE READING
18 Citations
44 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 44 references

Prospective validation of laparoscopic predictive model for optimal cytoreduction in advanced ovarian cancer

  • A Fagotti, G Ferradina, F Fanfani
  • Am J Obstet Gynecol 2008 [Epub ahead of print]
  • 2008
1 Excerpt

A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer

  • TD Yan, D Black, PH Sugarbaker
  • Ann Surg Oncol 2007;14:2702–2713
  • 2007
1 Excerpt

A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei

  • TD Yan, D Black, R Savady
  • Ann Oncol
  • 2007
1 Excerpt

Similar Papers

Loading similar papers…